http://seekingalpha.com/news/272033...ical-trials-in-japan?uprof=45&dr=1#email_link
Japan's Pharmaceuticals and Medical Devices Agency (PMDA) approvesPluristem Therapeutics' (NASDAQSTI) PLX-PAD cells for use in clinical trials in country. The clearance will enable the company to commence a Phase 2 study ofPLX-PAD in critical limb ischemia through Japan's accelerated regulatory pathway for regenerative medicine which allows for conditional, time-limited marketing approval after a single successful Phase 2 trial.The company intends to talk with the PDMA in Q4 to finalize the protocol. It expects to receive permission in Q4 to start the trial, which should commence in Q1 2016.
- Forums
- ASX - By Stock
- MSB
- Japan makes moves
Japan makes moves
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
95.5¢ |
Change
0.005(0.53%) |
Mkt cap ! $1.090B |
Open | High | Low | Value | Volume |
95.0¢ | 96.0¢ | 93.5¢ | $2.477M | 2.610M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 14809 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.5¢ | 10582 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 14809 | 0.950 |
6 | 135948 | 0.945 |
10 | 298638 | 0.940 |
7 | 79890 | 0.935 |
7 | 64150 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.955 | 10582 | 1 |
0.960 | 39943 | 3 |
0.965 | 15052 | 2 |
0.970 | 42352 | 4 |
0.975 | 14000 | 1 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online